Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GRB Technologies, now also operating under the Sphaira name, is a Quebec-based healthcare technology company developing infection-control devices for hospitals and other indoor environments. Its products are designed to reduce transmission of pathogens through contaminated surfaces and indoor air, with flagship technologies including LIBU, an antimicrobial elevator button, and LIFA, a UVC-based air sanitization device. The company appears to focus on non-drug prevention technologies rather than therapeutics, positioning itself at the intersection of medical devices, environmental hygiene, and public-health infrastructure. GRB/Sphaira has collaborated with Quebec research and innovation institutions and promotes its solutions primarily for healthcare settings and other high-risk enclosed spaces. Available evidence suggests it is a small, private, active Canadian company with early commercial activity and ongoing product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GRB Technologies.